Atrium Therapeutics Inc (RNA)

Short-Term Debt

$1.68M

Quarterly · Period ending: · USD

RNA logo

RNA Short-Term Debt

Latest reported$1.68M
RNA Quarterly Short-Term Debt ($3.97M → $1.68M)
High-resolution chart · PNG

RNA short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
1,683,000
2,680,000
3,672,000
3,967,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.